These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31784617)

  • 1. Hyperventilation-induced heart rate response as a potential marker for cardiovascular disease.
    Hawkins SM; Guensch DP; Friedrich MG; Vinco G; Nadeshalingham G; White M; Mongeon FP; Hillier E; Teixeira T; Flewitt JA; Eberle B; Fischer K
    Sci Rep; 2019 Nov; 9(1):17887. PubMed ID: 31784617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of cardiovascular magnetic resonance to detect oxygenation deficits in patients with multi-vessel coronary artery disease triggered by breathing maneuvers.
    Fischer K; Yamaji K; Luescher S; Ueki Y; Jung B; von Tengg-Kobligk H; Windecker S; Friedrich MG; Eberle B; Guensch DP
    J Cardiovasc Magn Reson; 2018 May; 20(1):31. PubMed ID: 29730991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Simulated Hyperventilation and Periodic Breathing on Sympatho-Vagal Balance and Hemodynamics in Patients with and without Heart Failure.
    Spiesshoefer J; Becker S; Tuleta I; Mohr M; Diller GP; Emdin M; Florian AR; Yilmaz A; Boentert M; Giannoni A
    Respiration; 2019; 98(6):482-494. PubMed ID: 31461730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart rate control in an unselected consecutive population of outpatients with stable coronary artery disease: Analysis of the CARDIf Study Cohort.
    Vitale C; Iellamo F; Volterrani M; Lombardi M; Fini M; Banach M; Rosano GM
    Angiology; 2010 Nov; 61(8):763-7. PubMed ID: 20462892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Blockade in Heart Failure With Reduced Ejection Fraction: Does Heart Rate Control Influence Readmissions?
    Owens RE; Twilla JD; Self TH; Alshaya AI; Metra CJ; Cummings C; Oliphant CS
    J Pharm Pract; 2018 Feb; 31(1):40-45. PubMed ID: 28737066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of heart rate responses to standing and hyperventilation at rest to detect coronary artery disease: correlation with the S-T response to exercise.
    Greenberg PS; Cooke BM; Bible M; Ellstad MH
    J Electrocardiol; 1980 Oct; 13(4):373-8. PubMed ID: 7430867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cheyne-Stokes respiration in heart failure: friend or foe? Hemodynamic effects of hyperventilation in heart failure patients and healthy volunteers.
    Oldenburg O; Spießhöfer J; Fox H; Bitter T; Horstkotte D
    Clin Res Cardiol; 2015 Apr; 104(4):328-33. PubMed ID: 25373383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term impact of β-blocker in elderly patients without myocardial infarction after percutaneous coronary intervention.
    Fukase T; Dohi T; Koike T; Yasuda H; Takeuchi M; Takahashi N; Chikata Y; Endo H; Doi S; Nishiyama H; Okai I; Iwata H; Okazaki S; Miyauchi K; Daida H; Minamino T
    ESC Heart Fail; 2022 Feb; 9(1):545-554. PubMed ID: 34811932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperventilation induces sympathetic overactivation in mesial temporal epilepsy.
    Assenza G; Mecarelli O; Tombini M; Pulitano P; Pellegrino G; Benvenga A; Assenza F; Campana C; Di Pino G; Di Lazzaro V
    Epilepsy Res; 2015 Feb; 110():221-7. PubMed ID: 25616476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heart rate: clinical variable and risk marker].
    Custodis F; Reil JC; Schirmer SH; Adam O; Möhlenkamp S; Laufs U; Böhm M
    Dtsch Med Wochenschr; 2014 Aug; 139(33):1661-8; quiz 1669-70. PubMed ID: 25093954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inadequate heart rate control is associated with worse quality of life in patients with coronary artery disease and chronic obstructive pulmonary disease. The RYTHMOS study.
    Andrikopoulos G; Pastromas S; Kartalis A; Toli K; Mantas I; Tzeis S; Kyrpizidis C; Olympios C; Manolis AJ; Foussas S; Kranidis A; Pras A; Pipilis A; Chryssos D; Gotsis A; Trikas A; Richter D; Alexopoulos D; Parthenakis F; Theodorakis G; Konstantinides S; Vardas P
    Hellenic J Cardiol; 2012 Mar; 53(2):118-26. PubMed ID: 22484777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart rate recovery--a potential marker of clinical outcomes in heart failure patients receiving beta-blocker therapy.
    Sheppard RJ; Racine N; Roof A; Ducharme A; Blanchet M; White M
    Can J Cardiol; 2007 Dec; 23(14):1135-8. PubMed ID: 18060099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registry.
    Tendera M; Fox K; Ferrari R; Ford I; Greenlaw N; Abergel H; Macarie C; Tardif JC; Vardas P; Zamorano J; Gabriel Steg P;
    Int J Cardiol; 2014 Sep; 176(1):119-24. PubMed ID: 25042656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial.
    Mentz RJ; Allen BD; Kwasny MJ; Konstam MA; Udelson JE; Ambrosy AP; Fought AJ; Vaduganathan M; O'Connor CM; Zannad F; Maggioni AP; Swedberg K; Bonow RO; Gheorghiade M
    Eur J Heart Fail; 2013 Jan; 15(1):61-8. PubMed ID: 22968743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart rate and heart rate variability in panic, social anxiety, obsessive-compulsive, and generalized anxiety disorders at baseline and in response to relaxation and hyperventilation.
    Pittig A; Arch JJ; Lam CW; Craske MG
    Int J Psychophysiol; 2013 Jan; 87(1):19-27. PubMed ID: 23107994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extent of heart rate reduction during hospitalization using beta-blockers, not the achieved heart rate itself at discharge, predicts the clinical outcome in patients with acute heart failure syndromes.
    Takahama H; Yokoyama H; Kada A; Sekiguchi K; Fujino M; Funada A; Amaki M; Hasegawa T; Asakura M; Kanzaki H; Anzai T; Kitakaze M
    J Cardiol; 2013 Jan; 61(1):58-64. PubMed ID: 23165149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart rate and use of beta-blockers in stable outpatients with coronary artery disease.
    Steg PG; Ferrari R; Ford I; Greenlaw N; Tardif JC; Tendera M; Abergel H; Fox KM;
    PLoS One; 2012; 7(5):e36284. PubMed ID: 22570699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the recombinant form of the natural human B-type natriuretic peptide and levosimendan on pulmonary hyperventilation and chemosensivity in heart failure.
    Bocchi EA; Moura LZ; Issa VS; Cruz F; Carvalho VO; Guimarães GV
    Cardiovasc Ther; 2013 Apr; 31(2):100-7. PubMed ID: 21884030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern of use of β-blockers in older patients with stable coronary artery disease: an observational, cross-sectional, multicentre survey.
    Vitale C; Spoletini I; Volterrani M; Iellamo F; Fini M
    Drugs Aging; 2011 Sep; 28(9):703-11. PubMed ID: 21913736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart rate dynamics during a treadmill cardiopulmonary exercise test in optimized beta-blocked heart failure patients.
    Carvalho VO; Guimarães GV; Ciolac EG; Bocchi EA
    Clinics (Sao Paulo); 2008 Aug; 63(4):479-82. PubMed ID: 18719758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.